ACAD

Acadia Pharmaceuticals Stock Price

27.42
0.00 (0.0%)
27.42

Low
19.20

52 Week Range

High
58.72

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Acadia Pharmaceuticals Inc ACAD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 27.42 08:22:19
Open Price Low Price High Price Close Price Prev Close
27.42
Bid Price Ask Price Spread News
26.89 27.40 0.51 - -
Trades Volume Avg Volume 52 Week Range
8 95 1,669,081 19.20 - 58.72
Last Trade Time Type Quantity Stock Price Currency
08:23:14 45 $ 27.10 USD

Acadia Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 4.39B 160.18M 98.68M $ 441.76M $ -248.53M -1.80 -16.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -14.17k 0.40%

more financials information »

Acadia Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ACAD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week23.7227.6023.6526.292,090,5643.7015.6%
1 Month21.50527.6020.6223.471,563,5495.9227.51%
3 Months27.8628.309919.2022.092,073,232-0.44-1.58%
6 Months51.7957.3419.2029.911,860,718-24.37-47.06%
1 Year44.9058.7219.2036.861,618,808-17.48-38.93%
3 Years16.4058.7212.7730.771,760,20211.0267.2%
5 Years37.8458.7212.7729.841,853,576-10.42-27.54%

Acadia Pharmaceuticals Description

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.


Your Recent History
NASDAQ
ACAD
Acadia Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.